Preferences and Utilities for Treatment Attributes in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy in the United Kingdom.
Saved in:
| Title: | Preferences and Utilities for Treatment Attributes in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy in the United Kingdom. |
|---|---|
| Authors: | Lo SH; Acaster Lloyd Consulting Ltd, Lacon House, 84 Theobalds Road, WC1X 8NL, London, UK., Gorni K; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Sutherland CS; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Martí Y; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Lloyd A; Acaster Lloyd Consulting Ltd, Lacon House, 84 Theobalds Road, WC1X 8NL, London, UK. andrew.lloyd@acasterlloyd.com., Paracha N; F. Hoffmann-La Roche Ltd, Basel, Switzerland. |
| Source: | PharmacoEconomics [Pharmacoeconomics] 2022 Apr; Vol. 40 (Suppl 1), pp. 91-102. Date of Electronic Publication: 2021 Oct 18. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34658007 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Preferences and Utilities for Treatment Attributes in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy in the United Kingdom. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lo+SH%22">Lo SH</searchLink>; Acaster Lloyd Consulting Ltd, Lacon House, 84 Theobalds Road, WC1X 8NL, London, UK.<br /><searchLink fieldCode="AU" term="%22Gorni+K%22">Gorni K</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sutherland+CS%22">Sutherland CS</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Martí+Y%22">Martí Y</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lloyd+A%22">Lloyd A</searchLink>; Acaster Lloyd Consulting Ltd, Lacon House, 84 Theobalds Road, WC1X 8NL, London, UK. andrew.lloyd@acasterlloyd.com.<br /><searchLink fieldCode="AU" term="%22Paracha+N%22">Paracha N</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229212404%22">PharmacoEconomics</searchLink> [Pharmacoeconomics] 2022 Apr; Vol. 40 (Suppl 1), pp. 91-102. <i>Date of Electronic Publication: </i>2021 Oct 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9212404 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-2027 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211707690%22">11707690 </searchLink><i>NLM ISO Abbreviation: </i>Pharmacoeconomics |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34658007 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40273-021-01092-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 91 Titles: – TitleFull: Preferences and Utilities for Treatment Attributes in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy in the United Kingdom. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lo SH – PersonEntity: Name: NameFull: Gorni K – PersonEntity: Name: NameFull: Sutherland CS – PersonEntity: Name: NameFull: Martí Y – PersonEntity: Name: NameFull: Lloyd A – PersonEntity: Name: NameFull: Paracha N IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2022 Apr Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1179-2027 Numbering: – Type: volume Value: 40 – Type: issue Value: Suppl 1 Titles: – TitleFull: PharmacoEconomics Type: main |
| ResultId | 1 |